Research ArticleClinical Studies
Time to Onset of Bendamustine-associated Skin Damage Using the Spontaneous Reporting System
MISUI KASHIWAGI, TADASHI SHIMIZU, RIKA KAWAI, TAKEHIRO KAWASHIRI, YOSHIHIRO UESAWA and MAYAKO UCHIDA
Anticancer Research May 2022, 42 (5) 2737-2741; DOI: https://doi.org/10.21873/anticanres.15752
MISUI KASHIWAGI
1Department of Education and Research Center for Pharmacy Practice, Faculty of Pharmaceutical Sciences, Doshisha Women’s College of Liberal Arts, Kyotanabe, Japan;
TADASHI SHIMIZU
2School of Pharmacy, Hyogo University of Health Sciences, Kobe, Japan;
RIKA KAWAI
1Department of Education and Research Center for Pharmacy Practice, Faculty of Pharmaceutical Sciences, Doshisha Women’s College of Liberal Arts, Kyotanabe, Japan;
TAKEHIRO KAWASHIRI
3Department of Clinical Pharmacy and Pharmaceutical Care, Graduate School of Pharmaceutical Sciences, Kyushu University, Fukuoka, Japan;
YOSHIHIRO UESAWA
4Department of Medical Molecular Informatics, Meiji Pharmaceutical University, Kiyose, Japan
MAYAKO UCHIDA
1Department of Education and Research Center for Pharmacy Practice, Faculty of Pharmaceutical Sciences, Doshisha Women’s College of Liberal Arts, Kyotanabe, Japan;
Log in using your username and password
Purchase access
You may purchase access to this article. This will require you to create an account if you don't already have one.
patientACCESS
patientACCESS - Patients desiring access to articles
In this issue
Time to Onset of Bendamustine-associated Skin Damage Using the Spontaneous Reporting System
MISUI KASHIWAGI, TADASHI SHIMIZU, RIKA KAWAI, TAKEHIRO KAWASHIRI, YOSHIHIRO UESAWA, MAYAKO UCHIDA
Anticancer Research May 2022, 42 (5) 2737-2741; DOI: 10.21873/anticanres.15752
Jump to section
Related Articles
- No related articles found.